FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395,999 | +1418.4% | 89,189 | +1028.5% | 0.00% | – |
| Q2 2023 | $26,080 | +435.1% | 7,903 | +362.2% | 0.00% | – |
| Q1 2023 | $4,874 | -61.8% | 1,710 | -2.5% | 0.00% | – |
| Q4 2022 | $12,762 | -20.2% | 1,753 | -8.7% | 0.00% | – |
| Q3 2022 | $16,000 | -11.1% | 1,920 | -48.7% | 0.00% | – |
| Q2 2022 | $18,000 | -97.4% | 3,740 | -87.2% | 0.00% | – |
| Q1 2022 | $691,000 | -3.4% | 29,228 | -27.7% | 0.00% | – |
| Q4 2021 | $715,000 | +247.1% | 40,433 | +452.7% | 0.00% | – |
| Q3 2021 | $206,000 | +182.2% | 7,315 | +5.7% | 0.00% | – |
| Q2 2021 | $73,000 | +247.6% | 6,919 | +297.4% | 0.00% | – |
| Q1 2021 | $21,000 | -50.0% | 1,741 | -51.5% | 0.00% | – |
| Q4 2020 | $42,000 | +740.0% | 3,592 | +422.9% | 0.00% | – |
| Q3 2020 | $5,000 | -84.4% | 687 | -60.4% | 0.00% | – |
| Q2 2020 | $32,000 | -27.3% | 1,737 | -52.8% | 0.00% | – |
| Q1 2020 | $44,000 | +193.3% | 3,679 | +303.4% | 0.00% | – |
| Q4 2019 | $15,000 | +650.0% | 912 | +281.6% | 0.00% | – |
| Q3 2019 | $2,000 | – | 239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |